Agreement to Acquire Clarendon Agricare

RNS Number : 3587X

Origin Enterprises Plc

20 March 2026

 

 

Agreement to Acquire Clarendon Agricare

 

Dublin, London, 20 March 2026: Origin Enterprises plc ('Origin' or the 'Company'), the international group championing sustainable land use solutions, today announces that it has agreed to acquire Clarendon Agricare Limited ("Clarendon"). Clarendon is a leading distributor of plant protection products and provides advice to distributors in the grassland, arable, horticulture and amenity sectors across Northern Ireland from its facility in Portadown, County Armagh.Welcoming the announcement, Sean Coyle, Chief Executive Officer, commented: "Clarendon Agricare is a well-established distributor within the Northern Ireland agricultural sector. This acquisition strengthens our plant protection distribution capability and supports the merchant channel with which we have positive relationship via our existing Fertiliser and Feed joint venture operations and our Origin Northern Ireland business. We look forward to working with the current executive team who will remain with the business post completion." The transaction is subject to completion conditions and is expected to complete in the coming weeks.

 

ENDS

 

 

Enquiries:
Origin Enterprises plc
Colm Purcell
Chief Financial Officer	Tel: +353 (0)1 563 4900
Brendan Corcoran
Head of Investors Relations and Sustainability	Tel: +353 (0)1 563 4900

 

About Origin Enterprises plc
Origin Enterprises plc champions sustainable land use through technically-led solutions, empowering our customers to enrich their land so it can achieve its true potential. The Group has leading market positions in Ireland, the United Kingdom, Brazil, Poland and Romania, and is listed on the Euronext Growth Dublin market and the AIM market of the London Stock Exchange.
Euronext Growth (Dublin) ticker symbol:	OIZ
AIM ticker symbol	OGN
Website:	www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.